{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:35:02Z","timestamp":1790634902003,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173824"],"award-info":[{"award-number":["82173824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204402"],"award-info":[{"award-number":["82204402"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpha.2025.101382","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:40:01Z","timestamp":1751427601000},"page":"101382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Promising TNF-\u03b1 inhibitors: Targeting pathogenic TNF-\u03b1\/TNFR signaling to restore Th17\/Treg balance in rheumatoid arthritis"],"prefix":"10.1016","volume":"16","author":[{"given":"Jiajie","family":"Kuai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101382_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2025.101382_bib2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101382_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101382_bib6","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpha.2025.101382_bib7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis","volume":"48","author":"Morgan","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpha.2025.101382_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib9","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpha.2025.101382_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101382_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib12","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41418-021-00834-8","article-title":"Lymphotoxin: From the physiology to the regeneration of the thymic function","volume":"28","author":"Borelli","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jpha.2025.101382_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106929","article-title":"TNFepitope: A webserver for the prediction of TNF-\u03b1 inducing epitopes","volume":"160","author":"Dhall","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood.2023022455","article-title":"Targeting the TNF\/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia","volume":"143","author":"\u00c1vila \u00c1vila","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jpha.2025.101382_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-024-02465-w","article-title":"Synovium microenvironment-responsive injectable hydrogel inducing modulation of macrophages and elimination of synovial fibroblasts for enhanced treatment of rheumatoid arthritis","volume":"22","author":"Wu","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.jpha.2025.101382_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433898","article-title":"E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes","volume":"15","author":"Meng","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/ph14040309","article-title":"The immunomodulatory and anti-inflammatory effect of curcumin on immune cell populations, cytokines, and in vivo models of rheumatoid arthritis","volume":"14","author":"Makuch","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jpha.2025.101382_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117420","article-title":"A TNF-\u03b1 blocking peptide that reduces NF-\u03baB and MAPK activity for attenuating inflammation","volume":"92","author":"Wang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpha.2025.101382_bib20","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.3390\/ijms23169306","article-title":"TNF-\u03b1 affects signature cytokines of Th1 and Th17 T cell subsets through differential actions on TNFR1 and TNFR2","volume":"23","author":"Pesce","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101382_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jdv.18770","article-title":"Polymorphisms in some proinflammatory genes (TNF\u03b1 and \u03b2, IL-1\u03b2, IL-6, ADAM17) in severe chronic venous disease","volume":"37","author":"Slonkov\u00e1","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jpha.2025.101382_bib22","doi-asserted-by":"crossref","first-page":"11599","DOI":"10.1021\/acsami.3c00131","article-title":"Targeting tumor necrosis factor receptor 1 with selected aptamers for anti-inflammatory activity","volume":"15","author":"Chu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jpha.2025.101382_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.smim.2014.02.005","article-title":"The TNF family in T cell differentiation and function \u2212 Unanswered questions and future directions","volume":"26","author":"Croft","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ni.3352","article-title":"SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants \u2212 past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jpha.2025.101382_bib27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.95.2.570","article-title":"The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor","volume":"95","author":"Grell","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2025.101382_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.celrep.2016.11.083","article-title":"Opposing functions of microglial and macrophagic TNFR2 in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"18","author":"Gao","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpha.2025.101382_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.12841","article-title":"Impaired T cell receptor signaling and development of T cell-mediated autoimmune arthritis","volume":"294","author":"Takeuchi","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpha.2025.101382_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/iid3.19","article-title":"Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity, Immun","volume":"2","author":"Polz","year":"2014","journal-title":"Inflamm. Dis."},{"key":"10.1016\/j.jpha.2025.101382_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101382_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4161\/cc.11.5.19300","article-title":"The role of TRADD in death receptor signaling","volume":"11","author":"Pobezinskaya","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jpha.2025.101382_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: Live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","article-title":"TNF-\u03b1 induces two distinct caspase-8 activation pathways","volume":"133","author":"Wang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101382_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101382_bib36","doi-asserted-by":"crossref","first-page":"23390","DOI":"10.1074\/jbc.M213237200","article-title":"Genetic deletion of the tumor necrosis factor receptor p60 or p80 sensitizes macrophages to lipopolysaccharide-induced nuclear factor-\u03baB, mitogen-activated protein kinases, and apoptosis","volume":"278","author":"Takada","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101382_bib37","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.1074\/jbc.M609146200","article-title":"Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling","volume":"282","author":"Zhao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101382_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib39","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/emboj\/16.5.1080","article-title":"Tumor necrosis factor \u03b1-induced activation of c-Jun N-terminal kinase is mediated by TRAF2","volume":"16","author":"Reinhard","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.jpha.2025.101382_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpha.2025.101382_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrrheum.2017.22","article-title":"Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases","volume":"13","author":"Croft","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.1102365","article-title":"CD3\u03b6-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation","volume":"189","author":"\u00c9rsek","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib43","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1182\/blood-2006-12-064170","article-title":"TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jpha.2025.101382_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","article-title":"TNF activity and T cells","volume":"101","author":"Mehta","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jpha.2025.101382_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.jpha.2025.101382_bib46","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpha.2025.101382_bib47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.201546241","article-title":"Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice","volume":"46","author":"Corneth","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib48","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41419-018-1266-6","article-title":"Differential roles of TNF\u03b1-TNFR1 and TNF\u03b1-TNFR2 in the differentiation and function of CD4+Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jpha.2025.101382_bib50","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.2101025","article-title":"A pathogenic Th17\/CD38+ macrophage feedback loop drives inflammatory arthritis through TNF-\u03b1","volume":"208","author":"Muench","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adg5678","article-title":"TNF-\u03b1 signals through ITK-Akt-mTOR to drive CD4+ T cell metabolic reprogramming, which is dysregulated in rheumatoid arthritis","volume":"17","author":"Bishop","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jpha.2025.101382_bib52","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib53","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.1500286","article-title":"Transmembrane TNF-TNFR2 impairs Th17 differentiation by promoting Il2 expression","volume":"195","author":"Miller","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110337","article-title":"Mechanisms of age-related Treg dysfunction in an arthritic environment","volume":"266","author":"Nishiyama","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103333","article-title":"Synovial regulatory T cells expressing ST2 deteriorate joint inflammation through the suppression of immunoregulatory eosinophils","volume":"149","author":"Hattori","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jpha.2025.101382_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24845","article-title":"MicroRNA-143-3p ameliorates collagen-induced arthritis by polarizing naive CD4+ T cells into Treg cells","volume":"37","author":"Shen","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jpha.2025.101382_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106859","article-title":"Rheumatoid arthritis autologous synovial fluid affects the plasticity and function of peripheral and induced T regulatory cells in vitro","volume":"267","author":"Kommoju","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jpha.2025.101382_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108858","article-title":"Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: New insights and challenges","volume":"108","author":"Rezaei Kahmini","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpha.2025.101382_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101941","article-title":"TNFR2 signalling in inflammatory diseases","volume":"38","author":"Williams","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib60","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2009.11.013","article-title":"Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients","volume":"69","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpha.2025.101382_bib61","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jpha.2025.101382_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","article-title":"Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR","volume":"19","author":"Zemmour","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.41134","article-title":"Involvement of tumor necrosis factor receptor type II in FoxP3 stability and as a marker of Treg cells specifically expanded by anti-tumor necrosis factor treatments in rheumatoid arthritis","volume":"72","author":"Santinon","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib64","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fimmu.2018.00573","article-title":"An autocrine TNF\u03b1-tumor necrosis factor receptor 2 loop promotes epigenetic effects inducing human Treg stability in vitro","volume":"9","author":"Urbano","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2019.04.018","article-title":"NF-\u03baB-driven miR-34a impairs Treg\/Th17 balance via targeting Foxp3","volume":"102","author":"Xie","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jpha.2025.101382_bib66","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41573-024-01053-9","article-title":"Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer","volume":"23","author":"Croft","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2025.101382_bib67","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-related infusion reactions: Systematic review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jpha.2025.101382_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00054725-199811000-00014","article-title":"Infliximab approved for use in Crohn's disease: A report on the FDA GI advisory committee conference, Inflamm","volume":"4","author":"Kornbluth","year":"1998","journal-title":"Bowel Dis."},{"key":"10.1016\/j.jpha.2025.101382_bib69","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (foreseeable) future of biological anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib70","first-page":"1095","article-title":"Immunologic parameters for disease activity in rheumatoid arthritis","volume":"76","author":"Mohsen","year":"2021","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.jpha.2025.101382_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10875-015-0182-0","article-title":"Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: A possible explanation for a lack of clinical response","volume":"35","author":"Talotta","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib72","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","volume":"205","author":"Notley","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF\u03b1 therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1196\/annals.1361.095","article-title":"Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab","volume":"1051","author":"Toubi","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpha.2025.101382_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cyto.2016.09.001","article-title":"TNF\u03b1 in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases","volume":"101","author":"Bystrom","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jpha.2025.101382_bib77","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib78","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/imt-2017-0155","article-title":"Etanercept for the treatment of rheumatoid arthritis","volume":"10","author":"Zhao","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jpha.2025.101382_bib79","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-\u03b1: Structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jpha.2025.101382_bib80","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cei.12626","article-title":"Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis","volume":"181","author":"Hull","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10067-013-2352-x","article-title":"The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: A follow-up study","volume":"33","author":"Szalay","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/ar3431","article-title":"Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy","volume":"13","author":"Chen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jpha.2025.101382_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2012.09.001","article-title":"Anti-TNF-\u03b1 therapy improves Treg and suppresses Teff in patients with rheumatoid arthritis","volume":"279","author":"Huang","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib84","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/ker183","article-title":"Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept","volume":"50","author":"Blache","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jpha.2025.101382_bib85","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpha.2025.101382_bib86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00063030-200620050-00005","article-title":"Adalimumab: A review of its use in adult patients with rheumatoid arthritis","volume":"20","author":"Cvetkovi\u0107","year":"2006","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpha.2025.101382_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11926-018-0769-6","article-title":"Review of biosimilar trials and data on adalimumab in rheumatoid arthritis","volume":"20","author":"Zhao","year":"2018","journal-title":"Curr. Rheumatol. Rep"},{"key":"10.1016\/j.jpha.2025.101382_bib88","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaci.2018.04.026","article-title":"Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis","volume":"142","author":"Nguyen","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib89","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.imbio.2011.07.006","article-title":"Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-\u03b3-producing NK cell and regulatory T cell subsets","volume":"216","author":"Aravena","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.jpha.2025.101382_bib90","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40259-016-0197-y","article-title":"Certolizumab pegol: A review in inflammatory autoimmune diseases","volume":"30","author":"Deeks","year":"2016","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpha.2025.101382_bib91","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: A comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2025.101382_bib92","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ibd.20225","article-title":"Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor \u03b1 agents","volume":"13","author":"Nesbitt","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jpha.2025.101382_bib93","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","article-title":"Tumor necrosis factor inhibitors - state of knowledge","volume":"10","author":"Lis","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jpha.2025.101382_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-021-02558-z","article-title":"Differential impacts of TNF\u03b1 inhibitors on the transcriptome of Th cells","volume":"23","author":"Ho","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jpha.2025.101382_bib95","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/ncomms4199","article-title":"TNF-\u03b1 blockade induces IL-10 expression in human CD4+ T cells","volume":"5","author":"Evans","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101382_bib96","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40259-017-0217-6","article-title":"Golimumab: A review in inflammatory arthritis","volume":"31","author":"Frampton","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpha.2025.101382_bib97","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/0091270009339192","article-title":"Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-\u03b1 human monoclonal antibody, in patients with psoriatic arthritis","volume":"49","author":"Xu","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101382_bib98","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/mabs.12304","article-title":"Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor \u03b1","volume":"2","author":"Shealy","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.jpha.2025.101382_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40259-017-0231-8","article-title":"Immunogenicity of biologics in chronic inflammatory diseases: A systematic review","volume":"31","author":"Strand","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jpha.2025.101382_bib100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/MIB.0b013e318280b169","article-title":"The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor \u03b1","volume":"19","author":"Ueda","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jpha.2025.101382_bib101","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrrheum.2014.34","article-title":"When TNF inhibitors fail in RA: Weighing up the options","volume":"10","author":"Silva-Fernandez","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib102","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1038\/s41598-025-90566-3","article-title":"Conducting a real-world study of tumor necrosis factor-\u03b1 inhibitors-induced systemic lupus erythematosus based on the FAERS database","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101382_bib103","article-title":"Characteristic analysis of adverse reactions of five anti-TNF\u0251 agents: A descriptive analysis from WHO-VigiAccess","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101382_bib104","article-title":"Risk of adverse events after anti-TNF treatment for inflammatory rheumatological disease. A meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101382_bib105","first-page":"37","article-title":"Stevens-Johnsons syndrome or drug-induced lupus - a clinical dilemma: A case report and review of the literature","volume":"9","author":"Bojinca","year":"2018","journal-title":"Biomed. Rep"},{"key":"10.1016\/j.jpha.2025.101382_bib106","first-page":"281","article-title":"Cutaneous side effects of TNF-alpha inhibitors","volume":"15","author":"Lindhaus","year":"2017","journal-title":"J. Dtsch. Dermatol. Ges"},{"key":"10.1016\/j.jpha.2025.101382_bib107","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40257-017-0296-7","article-title":"Clinical signs, pathophysiology and management of cutaneous side effects of anti-tumor necrosis factor agents","volume":"18","author":"Segaert","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jpha.2025.101382_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: A systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpha.2025.101382_bib109","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12026-016-8824-8","article-title":"Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: A comprehensive overview of methodology pitfalls and benefits","volume":"65","author":"Ogri\u010d","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jpha.2025.101382_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012567","article-title":"Risk of tuberculosis in patients treated with TNF-\u03b1 antagonists: A systematic review and meta-analysis of randomised controlled trials","volume":"7","author":"Zhang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpha.2025.101382_bib111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2217\/imt-2023-0058","article-title":"Summary of certolizumab pegol in psoriasis including structural features, pharmacokinetics and treatment","volume":"16","author":"Tokuyama","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jpha.2025.101382_bib112","first-page":"1","article-title":"Infection toxicity assessment of tumor necrosis factor \u03b1 inhibitors in the treatment of IBD: A real-world study based on the US food and drug administration adverse events reporting system (FAERS)","author":"Cheng","year":"2025","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpha.2025.101382_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2024.2444580","article-title":"Pulmonary toxicity assessment of tumor necrosis factor \u03b1 inhibitors in the treatment of IBD: A real world study based on US food and drug administration adverse events reporting system (FAERS)","author":"Sun","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jpha.2025.101382_bib114","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2017.11.024","article-title":"TNF-\u03b1-induced protein 3 (TNFAIP3)\/A20 acts as a master switch in TNF-\u03b1 blockade-driven IL-17A expression","volume":"142","author":"Urbano","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib115","doi-asserted-by":"crossref","first-page":"21666","DOI":"10.1073\/pnas.1909687116","article-title":"TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells","volume":"116","author":"Tseng","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2025.101382_bib116","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaci.2017.02.015","article-title":"Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease, J","volume":"140","author":"Cook","year":"2017","journal-title":"Allergy Clin. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/apc.2022.0197","article-title":"Biologic therapies in HIV\/AIDS patients with inflammatory diseases: A systematic review of the literature","volume":"37","author":"Bang","year":"2023","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jpha.2025.101382_bib118","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014043118","article-title":"Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells","volume":"118","author":"Ronin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2025.101382_bib119","doi-asserted-by":"crossref","first-page":"30639","DOI":"10.1073\/pnas.2007935117","article-title":"Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells","volume":"117","author":"Hu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.jpha.2025.101382_bib120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-018-0764-z","article-title":"Cutaneous manifestations of reactions to biologics","volume":"18","author":"Otani","year":"2018","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jpha.2025.101382_bib121","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41584-021-00639-6","article-title":"Insights into the biology and therapeutic implications of TNF and regulatory T cells","volume":"17","author":"Salomon","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib122","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40265-022-01821-0","article-title":"Ozoralizumab: First approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jpha.2025.101382_bib123","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1136\/ard.2008.102103","article-title":"Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases","volume":"68","author":"Burmester","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpha.2025.101382_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12969-015-0054-4","article-title":"Tuberculosis in pediatric patients treated with anti-TNF\u03b1 drugs: A cohort study, Pediatr","volume":"13","author":"Calzada-Hern\u00e1ndez","year":"2015","journal-title":"Rheumatol. Online J."},{"key":"10.1016\/j.jpha.2025.101382_bib125","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.38755","article-title":"Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis","volume":"66","author":"McCann","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122543","article-title":"Stimulus-responsive and dual-target DNA nanodrugs for rheumatoid arthritis treatment","volume":"632","author":"Zhang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2025.101382_bib127","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chembiol.2023.10.003","article-title":"Photoaffinity labeling coupled with proteomics identify PDI-ADAM17 module is targeted by (\u2212)-vinigrol to induce TNFR1 shedding and ameliorate rheumatoid arthritis in mice","volume":"31","author":"Zhu","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jpha.2025.101382_bib128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.40413","article-title":"Selective activation of tumor necrosis factor receptor II induces antiinflammatory responses and alleviates experimental arthritis","volume":"70","author":"Fischer","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpha.2025.101382_bib129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cmi.2017.138","article-title":"Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice","volume":"16","author":"Lamontain","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2025.101382_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw5422","article-title":"cIAP1\/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs","volume":"5","author":"Kawalkowska","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jpha.2025.101382_bib131","first-page":"1718","article-title":"NSC1122002, a TRAF-binding domain inhibitor, inhibits collagen-induced arthritis in a mouse model","volume":"40","author":"Pan","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jpha.2025.101382_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2757-z","article-title":"Modulating TRADD to restore cellular homeostasis and inhibit apoptosis","volume":"587","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101382_bib133","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41401-024-01450-1","article-title":"TRADD-mediated pyroptosis contributes to diabetic cardiomyopathy","volume":"46","author":"Zheng","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpha.2025.101382_bib134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41420-023-01406-0","article-title":"Inhibition of TRADD ameliorates chondrocyte necroptosis and osteoarthritis by blocking RIPK1-TAK1 pathway and restoring autophagy","volume":"9","author":"Sun","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jpha.2025.101382_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abi8713","article-title":"An orally active, small-molecule TNF inhibitor that disrupts the homotrimerization interface improves inflammatory arthritis in mice","volume":"15","author":"Javaid","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jpha.2025.101382_bib136","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41467-020-20828-3","article-title":"Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF","volume":"12","author":"McMillan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101382_bib137","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2018.05.058","article-title":"A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor \u03b1","volume":"547","author":"Liu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2025.101382_bib138","article-title":"CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases","volume":"11","author":"Vukovic","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jpha.2025.101382_bib139","article-title":"Inventors; A paeonol ester derivative and a preparation method and use thereof","author":"Wei","year":"2021","journal-title":"China invention patent CN 111217726 B"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:38:22Z","timestamp":1776371902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2095177925001996"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101382","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising TNF-\u03b1 inhibitors: Targeting pathogenic TNF-\u03b1\/TNFR signaling to restore Th17\/Treg balance in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101382"}}